Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Germing

Showing results (151-160 of 339) with videos related to

Pageof 34
Sort By:
JCO Clinical Cancer Informatics|December 23, 2025
Dynamic Mortality Risk Prediction in Myelodysplastic Syndromes Using Longitudinal Clinical DataJonathan Bobak, Philipp Spohr, Sarah Richter, et al.
European Journal of Haematology|January 21, 2015
Cellularity, characteristics of hematopoietic parameters and prognosis in myelodysplastic syndromesJennifer Schemenau, Stephan Baldus, Martin Anlauf, et al.
The Journal of Experimental Medicine|April 12, 2003
Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleenStephanie Kruetzmann, M Manuela Rosado, Holger Weber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2009
Novel TET2 mutations associated with UPD4q24 in myelodysplastic syndromeAzim M Mohamedali, Alexander E Smith, Joop Gaken, et al.
Haematologica|July 9, 2013
Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromesMarta Fernandez-Mercado, Adam Burns, Andrea Pellagatti, et al.
Annals of Hematology|August 6, 2018
Long-term outcome of high risk patients with myelodysplastic syndromes or secondary acute myeloid leukemia receiving intensive chemotherapyEsther Schuler, Natalie Zadrozny, Sabine Blum, et al.
Annals of Hematology|January 26, 2008
The sepsis-related Organ Failure Assessment (SOFA) score is predictive for survival of patients admitted to the intensive care unit following allogeneic blood stem cell transplantationFrank Neumann, Oliver Lobitz, Roland Fenk, et al.
Haematologica|January 19, 2019
Deep sequencing of bone marrow microenvironments of patients with del(5q) myelodysplastic syndrome reveals imprints of antigenic selection as well as generation of novel T-cell clusters as a response pattern to lenalidomideThorben Mährle, Nuray Akyüz, Pim Fuchs, et al.
Marine Drugs|September 8, 2019
First Results from a Screening of 300 Naturally Occurring Compounds: 4,6-dibromo-2-(2',4'-dibromophenoxy)phenol, 4,5,6-tribromo-2-(2',4'-dibromophenoxy)phenol, and 5-epi-nakijinone Q as Substances with the Potential for Anticancer TherapySaskia Mayer, Marie Prechtl, Pia Liebfried, et al.
Haematologica|June 29, 2014
Response to azacitidine is independent of p53 expression in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemiaCatharina Müller-Thomas, Martina Rudelius, Ina-Christine Rondak, et al.
Pageof 34

Showing results (151-160 of 339) with videos related to

Sort By:
Pageof 34
JCO Clinical Cancer Informatics|December 23, 2025
Dynamic Mortality Risk Prediction in Myelodysplastic Syndromes Using Longitudinal Clinical DataJonathan Bobak, Philipp Spohr, Sarah Richter, et al.
European Journal of Haematology|January 21, 2015
Cellularity, characteristics of hematopoietic parameters and prognosis in myelodysplastic syndromesJennifer Schemenau, Stephan Baldus, Martin Anlauf, et al.
The Journal of Experimental Medicine|April 12, 2003
Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleenStephanie Kruetzmann, M Manuela Rosado, Holger Weber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2009
Novel TET2 mutations associated with UPD4q24 in myelodysplastic syndromeAzim M Mohamedali, Alexander E Smith, Joop Gaken, et al.
Haematologica|July 9, 2013
Targeted re-sequencing analysis of 25 genes commonly mutated in myeloid disorders in del(5q) myelodysplastic syndromesMarta Fernandez-Mercado, Adam Burns, Andrea Pellagatti, et al.
Annals of Hematology|August 6, 2018
Long-term outcome of high risk patients with myelodysplastic syndromes or secondary acute myeloid leukemia receiving intensive chemotherapyEsther Schuler, Natalie Zadrozny, Sabine Blum, et al.
Annals of Hematology|January 26, 2008
The sepsis-related Organ Failure Assessment (SOFA) score is predictive for survival of patients admitted to the intensive care unit following allogeneic blood stem cell transplantationFrank Neumann, Oliver Lobitz, Roland Fenk, et al.
Haematologica|January 19, 2019
Deep sequencing of bone marrow microenvironments of patients with del(5q) myelodysplastic syndrome reveals imprints of antigenic selection as well as generation of novel T-cell clusters as a response pattern to lenalidomideThorben Mährle, Nuray Akyüz, Pim Fuchs, et al.
Marine Drugs|September 8, 2019
First Results from a Screening of 300 Naturally Occurring Compounds: 4,6-dibromo-2-(2',4'-dibromophenoxy)phenol, 4,5,6-tribromo-2-(2',4'-dibromophenoxy)phenol, and 5-epi-nakijinone Q as Substances with the Potential for Anticancer TherapySaskia Mayer, Marie Prechtl, Pia Liebfried, et al.
Haematologica|June 29, 2014
Response to azacitidine is independent of p53 expression in higher-risk myelodysplastic syndromes and secondary acute myeloid leukemiaCatharina Müller-Thomas, Martina Rudelius, Ina-Christine Rondak, et al.
Pageof 34